Page 4 - ஆல்பா சுகாதாரம் கையகப்படுத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Key partnership with Fresenius Humacyte was founded in 2004, and the Biotechnology Center provided it a $150,000 Small Business Research Loan in 2006. Since then Humacyte has raised nearly $480 million, including a $150 million equity investment from Fresenius Medical Care, the world’s leading provider of products and services for patients with renal diseases and for surgical care centers. “Humacyte is a world-class regenerative medicine company developing bioengineered tissues to treat unmet medical needs,” said Vivian Doelling, Ph.D., NCBiotech’s vice president of Emerging Company Development. “The company has been a trailblazer in these advanced and readily available technologies. It’s one of the best examples of North Carolina-based ingenuity and medical advancement.”

New yorkUnited statesAl iskandariyahNorth carolinaDuke universityMorgan creekHumacyte laura niklasonLaura niklasonVivian doellingRajiv shuklaJuliana blumRobert langerShannon dahlCompany developmentCarolina biotechnology centerMassachusetts institute of technology